StageDebt | Dead
About Therabron Therapeutics
Therabron Therapeutics, forrmerly Clarassance, is a clinical-stage biotechnology company that develops protein drugs to treat respiratory diseases. The company's products aim to restore the natural immune balance in the lungs of respiratory patients through the administration of synthetic human CC10 proteins. The family of CC10 proteins, also known as secretoglobins, have the potential to change the course of acute and chronic respiratory diseases, representing large markets into which few truly novel drugs have been introduced in the past several decades. Therabron's products have the potential to be first-to-market, first-in-class, disease-modifying, break-through biologics.
Missing: Therabron Therapeutics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Therabron Therapeutics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Therabron Therapeutics Patents
Therabron Therapeutics has filed 9 patents.
Transcription factors, Inflammations, Lung disorders, Pneumonia, Syndromes
Transcription factors, Inflammations, Lung disorders, Pneumonia, Syndromes
Latest Therabron Therapeutics News
Oct 10, 2022
Bronchitis Drug Market Segmentation, Operating Business Segments 2031 Pune, Maharashtra, India, October 10 2022 (Wiredrelease) Prudour Pvt. Ltd –:Market.us launches a comprehensive study of market segmentation, drivers, constraints, regional analysis, trends and forecast of Bronchitis Drug Market . A precise competitive analysis allows businesses to keep up-to-date with the latest market operations and even those of competitors. It is important to identify the strengths and weaknesses of top players so that you can make better business decisions. A major market trend is high investments in the research and manufacturing of new entrants. This report is part of our extensive portfolio of industry analysis that enables our clients to evaluate the most promising areas in the market and exploit key business opportunities. The Bronchitis Drug Market research study focuses on microeconomical factors such as Supply & Demand. It determines the price and volume of the product/service, as well as company profitability. Supply & Demand allows you to see the effects of external factors on product prices and volumes. Companies must understand the supply-demand situation for the market over a long and short time period. It is crucial to understand the relationship between price of a product/service and demand for consumer surplus when developing strategies. Data analyses from our study show that there will be enormous commercial opportunities for Bronchitis Drug manufacturers over the coming years, given the number of high-revenue-generating biologics that will go off patent in the next five years, and promising revenue forecasts for Bronchitis Drug in late-stage development. Find highlights on the growth strategies adopted by vendors and their product offerings | Request Sample Report Companies mentioned: Therabron Therapeutics Inc Geographically, the Bronchitis Drug market can be broken down into North America, Europe, Asian Pacific, Latin America, Middle East and Africa, and Rest of the World (ROW). A regional outlook can help you understand the product revenue, growth rate and volume for various countries. This information allows users to create a marketing strategy that is specific to their region. A research report can help you discover new opportunities for the product/service within different regions. This study utilized various analytical tools such as Porter’s 5 Forces model and SWOT analysis. It also included market sizing, top-down and bottom-up research. Porter’s 5 Forces model allows you to identify the competitive advantages of a business in the market. The PESTLE analysis can measure the impact of political, economic, social, and technological factors. SWOT helps companies to understand their current position. It is primarily based on strengths and weaknesses. A bottom-up model that uses micro attributes to estimate the market. This market research study also uses top-down and value-chain analysis models. The Report Covers – Each market segment’s annualized market revenue ($ million). – A country-by-country analysis of the major geographic regions. – Companies that are active in the global Bronchitis Drug industry. This report contains data on new product launches as well as relevant news. – Analysis of business strategies by identifying the key market segments positioned for strong growth in the future. – Market entry and expansion strategies analysis. – Competitive strategies by identifying ‘who stands where’ in the market. Market Scope: #Trends: The report discusses the many features that have an impact on the growth and future prospects of the Bronchitis Drug market. Positive factors that are influencing the market and restraining factors that are limiting its growth. They also discuss the impact on the global market. The market report also discusses other qualitative and quantitative factors, such as the risks involved in operations and the major challenges facing market key players. #Challenges: The study examines the major adoption trends in the Bronchitis Drug sector, as well as any issues that might hinder its growth. These elements are critical to product planning and design. This study provides an in-depth analysis of the trends and obstacles that exist in the Bronchitis Drug industry. #Statistics: The market size and share values of the Bronchitis Drug industry are provided in the report. It aids in understanding the market. Additionally, the report estimates upfront statistics and data that will be very useful to individuals involved in advertising and industry decision-making in the Bronchitis Drug. Reasons to buy – Find out how regulations or legal changes could affect the market – Identify market potential Key Questions answered in the Bronchitis Drug Market Report are: How does the global Bronchitis Drug Market look like in 2021? How many companies are currently involved in Bronchitis Drug development? Which are the most active in the pipeline? What is the size of the global Bronchitis Drug market? Which product segment grabbed the largest share in the Bronchitis Drug market? How much revenue will promise Bronchitis Drug in the market, and in development, record to 2032? How is the competitive scenario of the Bronchitis Drug market? Which are the key factors aiding the Bronchitis Drug market growth? Which region holds the maximum share in the Bronchitis Drug market? Which application segment emerged as the leading segment in the Bronchitis Drug market? Which are the prominent players in the Bronchitis Drug market? What are the regulatory evidence requirements in each country? Grab the full detailed report here: https://market.us/report/bronchitis-drug-market/ Ask before you buy Is this Market.us research? – Yes, Market.us has expert analysts who conducted the research and They used a mix of primary and indirect research. A research analyst can provide more details about the research process. Market.us follows which research methodology? – Market.us follows a methodology that includes the demand-side assessment and triangulates the market through supply-side analysis. This methodology is based on the standard market structure and methods. Who are the respondents in primary research? – Market.us speaks with stakeholders across the spectrum. This includes C-level executives, distributors and product manufacturers as well as industry experts. Please contact us to get a complete list. What sources are available for secondary research? – Market.us conducts an extensive secondary investigation using proprietary databases, paid databases, and information that is public. Our research papers include press releases from industry associations, annual reports of companies, investor presentations, investor presentations, and press releases . Information about desk research can be obtained upon request. Is it possible to obtain a sample from this report for evaluation? – Yes. A sample can be requested and sent via email ( email@example.com ) What is the best way to buy this report? – You can buy reports online with ease using our secure online payment system. The report can be purchased securely and safely online. Trending Reports (Book Now with Save 25% [Single User], 38% [Multi-User], 45% [Corporate Users] + Covid-19 scenario+ Impact of Russia-Ukraine war):
Therabron Therapeutics Frequently Asked Questions (FAQ)
Where is Therabron Therapeutics's headquarters?
Therabron Therapeutics's headquarters is located at 9430 Key West Avenue, Rockville.
What is Therabron Therapeutics's latest funding round?
Therabron Therapeutics's latest funding round is Debt.
How much did Therabron Therapeutics raise?
Therabron Therapeutics raised a total of $21.62M.
Who are the investors of Therabron Therapeutics?
Investors of Therabron Therapeutics include New Markets Venture Partners, Brace Pharma Capital, Zell Biotech Funds and U.S. Army.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.